Resources

iFyber to Attend the Kilmer Conference

iFyber is excited to announce its participation in the upcoming Kilmer Conference, taking place in Orlando, FL, from February 4-6, 2025. 

The team will present cutting-edge research on the application of Supercritical Carbon Dioxide (scCO2) inactivating viruses in birth tissue. The session explores the ability of scCO2 sterilization technology effectively inactivate porcine parvovirus in amnionic membranes—potentially allowing for more of the birth tissue to be used for wound care treatments.

ePoster Topic: Inactivation of Virus-spiked Amnion using Supercritical CO2

Date: Tuesday, February 4th during the poster session

About iFyber: 

iFyber is a full-service contract research organization (CRO) specializing in preclinical research services that support R&D teams in the development and approval of new products in industries including medical devices, wound care, diagnostics, and more.

Through high-touch support and scientific expertise, iFyber strives to improve healthcare and patient outcomes by helping clients turn innovative technology into market-ready products that improve lives.

About the Kilmer Conference:

The Kilmer Conference, organized by AAMI in collaboration with the Parenteral Drug Association, is a leading event focused on advancements in sterility assurance, microbiological quality, and infection prevention. Named after Fred Kilmer, a pioneer in the field, it serves as a collaborative forum for professionals from industry, academia, regulatory bodies, and healthcare to exchange ideas, share innovations, and drive progress in these critical areas.